NASDAQ : RKTO
Rocket One Inc. — Financial statements
Healthcare · Medical - Pharmaceuticals · United States
Last price 0.4867 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 12.12M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 6.75M | 6.41M | 4.97M | 4.21M | 6.13M | 6.57M |
| Research & Development | 6.42M | 5.95M | 3.25M | 3.74M | 4.93M | 7.53M |
| Operating Expenses | 13.17M | 12.36M | 8.22M | 7.95M | 11.07M | 14.10M |
| Operating Income | -13.17M | -12.36M | -8.22M | -7.95M | -11.07M | -14.10M |
| Interest & Investment Income | 624.00 | 680.00 | 27.71K | 51.77K | 67.28K | |
| Other Non Operating Income (Expenses) | -152.80K | -108.63K | 451.14K | -59.58K | ||
| EBT Excluding Unusual Items | -13.32M | -12.47M | -8.19M | -7.90M | -10.55M | -14.16M |
| Gain (Loss) on Sale of Investments | -581.00 | -204.92K | -824.82K | -152.68K | ||
| Pretax Income | -13.32M | -12.47M | -8.19M | -8.11M | -11.37M | -14.31M |
| Net Income | -13.32M | -12.47M | -8.19M | -8.11M | -11.37M | -14.31M |
| Preferred Dividends & Other Adjustments | -990.00 | |||||
| Net Income to Common | -13.32M | -12.47M | -8.19M | -8.11M | -11.37M | -14.31M |
| Shares Outstanding (Basic) | 16.42M | 13.81M | 6.38M | 3.41M | 1.20M | 893.23K |
| Shares Outstanding (Diluted) | 16.42M | 13.81M | 6.38M | 3.41M | 1.20M | 893.23K |
| EPS (Basic) | -0.81 | -0.90 | -1.28 | -2.38 | -9.50 | -16.02 |
| EPS (Diluted) | -0.81 | -0.90 | -1.28 | -2.38 | -9.50 | -16.02 |
| Free Cash Flow | -10.66M | -9.80M | -6.98M | -8.45M | -9.30M | -12.09M |
| Free Cash Flow Per Share | -0.65 | -0.71 | -1.09 | -2.48 | -7.76 | -13.54 |
| EBITDA | -14.10M | |||||
| D&A For EBITDA | 1.04K | |||||
| EBIT | -13.17M | -12.36M | -8.22M | -7.95M | -11.07M | -14.10M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 7.89M | 6.25M | 7.04M | 9.29M | 6.43M | 8.54M |
| Short-Term Investments | 209.32K | 1.89M | ||||
| Cash & Short-Term Investments | 7.89M | 6.25M | 7.04M | 9.29M | 6.64M | 10.43M |
| Other Receivables | 46.77K | 46.77K | ||||
| Receivables | 46.77K | 46.77K | 50.00K | |||
| Prepaid Expenses | 689.01K | 366.55K | 559.18K | 811.36K | 88.45K | 93.97K |
| Other Current Assets | 248.54K | |||||
| Total Current Assets | 8.58M | 6.86M | 7.64M | 10.15M | 6.73M | 10.58M |
| Property, Plant & Equipment | 4.65K | 31.07K | 55.16K | |||
| Long-Term Investments | 36.82K | 36.82K | 36.82K | 37.40K | 33.00K | 410.00K |
| Other Long-Term Assets | 967.13K | 699.42K | ||||
| Total Assets | 9.58M | 7.60M | 7.71M | 10.24M | 6.76M | 10.99M |
| Accounts Payable | 1.00M | 823.67K | 412.07K | 35.59K | 694.99K | 360.96K |
| Accrued Expenses | 379.79K | 623.32K | 390.76K | 614.23K | 692.74K | 506.82K |
| Current Portion of Leases | 5.68K | 28.37K | 28.84K | |||
| Total Current Liabilities | 1.38M | 1.45M | 831.20K | 678.66K | 1.39M | 867.79K |
| Long-Term Leases | 2.71K | 26.33K | ||||
| Other Long-Term Liabilities | 250.00K | 235.00K | ||||
| Total Liabilities | 1.38M | 1.45M | 833.91K | 704.98K | 1.64M | 1.10M |
| Common Stock | 2.32K | 1.55K | 804.00 | 435.00 | 130.00 | 96.00 |
| Additional Paid-In Capital | 87.59M | 79.02M | 67.28M | 61.73M | 50.20M | 43.59M |
| Retained Earnings | -79.41M | -72.88M | -60.41M | -52.22M | -45.10M | -33.73M |
| Comprehensive Income & Other | 11.34K | 10.83K | 9.06K | 27.26K | 22.01K | 17.59K |
| Total Common Equity | 8.20M | 6.15M | 6.88M | 9.54M | 5.12M | 9.88M |
| Shareholders' Equity | 8.20M | 6.15M | 6.88M | 9.54M | 5.12M | 9.88M |
| Total Liabilities & Equity | 9.58M | 7.60M | 7.71M | 10.24M | 6.76M | 10.99M |
| Total Debt | 5.68K | 31.07K | 55.16K | |||
| Net Cash (Debt) | 7.89M | 6.24M | 7.01M | 9.24M | 6.64M | 10.43M |
| Net Cash Per Share | 0.48 | 0.45 | 1.10 | 2.71 | 5.54 | 11.68 |
| Filing Date Shares Outstanding | 24.90M | 16.26M | 13.17M | 4.40M | 3.30M | 959.00K |
| Total Common Shares Outstanding | 23.18M | 15.51M | 8.04M | 4.35M | 1.30M | 958.98K |
| Working Capital | 7.20M | 5.41M | 6.81M | 9.47M | 5.34M | 9.71M |
| Book Value Per Share | 0.35 | 0.40 | 0.86 | 2.19 | 3.93 | 10.30 |
| Tangible Book Value | 8.20M | 6.15M | 6.88M | 9.54M | 5.12M | 9.88M |
| Tangible Book Value Per Share | 0.35 | 0.40 | 0.86 | 2.19 | 3.93 | 10.30 |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -13.32M | -12.47M | -8.19M | -8.11M | -11.37M | -14.31M |
| Depreciation & Amortization | 26.42K | 26.42K | ||||
| Asset Writedown & Restructuring Costs | 850.50K | 34.00K | 92.47K | |||
| Loss (Gain) From Sale of Investments | 581.00 | 204.92K | 824.82K | 218.78K | ||
| Stock-Based Compensation | 1.92M | 1.52M | 804.28K | 216.43K | 620.80K | 1.32M |
| Other Operating Activities | 123.13K | 83.24K | -275.00K | 59.58K | ||
| Change in Accounts Payable | 1.04M | 644.17K | 153.01K | -700.75K | 590.63K | 535.34K |
| Change in Other Net Operating Assets | -454.02K | -460.02K | 252.18K | 213.43K | 3.85K | -5.42K |
| Operating Cash Flow | -10.66M | -9.80M | -6.98M | -8.45M | -9.30M | -12.09M |
| Sale (Purchase) of Intangibles | -74.00K | -116.97K | ||||
| Investment in Securities | 1.24M | -48.38K | ||||
| Other Investing Activities | -152.80K | -300.00K | ||||
| Investing Cash Flow | -152.80K | -300.00K | 1.16M | -165.35K | ||
| Issuance of Common Stock | 10.13M | 9.74M | 4.74M | 11.32M | 5.99M | 18.19M |
| Repurchase of Common Stock | -376.00K | -376.00K | ||||
| Other Financing Activities | -57.17K | -57.17K | 50.00K | |||
| Financing Cash Flow | 9.69M | 9.31M | 4.74M | 11.32M | 6.04M | 18.19M |
| Foreign Exchange Rate Adjustments | -703.00 | 1.77K | -18.20K | -6.52K | -9.59K | -30.56K |
| Net Cash Flow | -1.12M | -791.46K | -2.25M | 2.86M | -2.11M | 5.91M |
| Free Cash Flow | -10.66M | -9.80M | -6.98M | -8.45M | -9.30M | -12.09M |
| Free Cash Flow Per Share | -0.65 | -0.71 | -1.09 | -2.48 | -7.76 | -13.54 |
| Levered Free Cash Flow | -4.89M | -5.54M | -3.93M | -6.26M | -5.79M | -7.11M |
| Unlevered Free Cash Flow | -4.89M | -5.54M | -3.93M | -6.26M | -5.79M | -7.11M |
| Change in Working Capital | 586.41K | 184.15K | 405.19K | -487.32K | 594.48K | 529.92K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 12.12M | 15.36M | 5.76M | 6.26M | 10.14M | 15.82M |
| Enterprise Value | 4.23M | 7.52M | -2.23M | -5.59M | 877.00K | 1.34M |
| Last Close Price | 0.49 | 0.99 | 0.75 | 1.44 | 7.80 | 16.50 |
| PB Ratio | 1.38 | 2.50 | 0.84 | 0.66 | 1.98 | 1.60 |
| P/TBV Ratio | 1.48 | 2.50 | 0.84 | 0.66 | 1.98 | 1.60 |
| Debt / Equity Ratio | 0.00 | 0.01 | 0.01 | |||
| Net Debt / Equity Ratio | -0.96 | -1.01 | -1.02 | -0.97 | -1.30 | -1.06 |
| Net Debt / EBITDA Ratio | 0.74 | |||||
| Net Debt / FCF Ratio | 0.74 | 0.64 | 1.00 | 1.09 | 0.71 | 0.86 |
| Quick Ratio | 5.70 | 4.30 | 8.53 | 13.76 | 4.78 | 12.02 |
| Current Ratio | 6.20 | 4.72 | 9.20 | 14.96 | 4.85 | 12.19 |
| Return on Equity (ROE) | -148.47% | -191.40% | -99.75% | -110.59% | -151.59% | -197.05% |
| Return on Assets (ROA) | -83.59% | -100.88% | -57.19% | -58.47% | -77.95% | -108.62% |
| Return on Capital Employed (ROCE) | -160.60% | -201.00% | -119.40% | -83.20% | -206.00% | -139.40% |
| Earnings Yield | -166.71% | -81.19% | -142.15% | -129.51% | -112.12% | -90.48% |
| FCF Yield | -87.99% | -63.83% | -121.14% | -134.96% | -91.67% | -76.42% |
| Buyback Yield / Dilution | -63.58% | -116.56% | -87.00% | -184.69% | -34.07% | -80.63% |